Revolutionizing vaccine discovery
through state-of-the-art mass spectrometry-based proteomics
The field of proteomics has come of age. As leaders in this field, we founded ID-Antigens to bring biological discovery to the 21st century. Our platform is focused on depth, reaching far into proteomes and protein post-translational modifications, while maintaining high quantitative fidelity across both microbial and human cellular biology.
Using the highest scientific standards, ID-Antigens aims to:
1) capitalize on cutting-edge proteomics to advance novel vaccine antigen discovery against infectious diseases caused by microbes andÂ
2) provide state-of-the-art proteomics services to researchers and clinicians throughout the research community.
VISION
Eradicating infectious diseases for a safer tomorrow.
MISSION
ID-Antigens has a twofold mission:
1) discovery and validation of vaccine antigens by exploring uncharted proteomes in pathogenic microorganisms and
2) provision of first-class proteomics services.
APPROACH
The Unexplored World of the Microbial Proteome
Even though microbial proteins have been studied for decades, a significant portion of predicted microbial proteomes remains unidentified or uncharacterized. The role and importance of these proteins in the virulence of pathogenic microorganisms remains unknown and the therapeutic potential of these unexplored vaccine targets remains untapped.
ID-Antigens addresses this challenge with state-of-the-art mass spectrometry-based proteomics technology that allows for global detection and unbiased profiling of proteins in a way few methods can match. Our modern microbiology culturing methods, molecular biology tools, and genetic engineering techniques allow proteomics discoveries to move beyond observation and provide unlimited biological possibilities.
By asking the proper scientific questions, using appropriate molecular tools, and applying our cutting-edge proteomics techniques, we chart the elusive domain of microbial proteomes to accelerate the discovery of the next generation of vaccines.
BRINGING ADVANCEMENTS IN PROTEOMICS TO THE RESEARCH COMMUNITY
With our proven track record of field-leading excellence, ID-Antigens offers advanced proteomics workflows as a service to the research community. Please see our Services Page for more details.